X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Metabolomics

期刊標題檢索 METABOLOMICS 最新評論: The review process is very slow, the editor said they couldn't find re... (2023-12-20)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Metabolomics]您好,您是該頁面的第 54649 位訪客。

期刊簡介
期刊名稱Metabolomics Metabolomics
LetPub Score
6.3
50 ratings
Rate

Reputation
7.5

Influence
5.1

Speed
7.0

期刊簡稱METABOLOMICS
ISSN1573-3882
E-ISSN1573-3890
h-index65
CiteScore
CiteScoreSJRSNIPCiteScore Rank
7.900.7621.002
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Endocrinology, Diabetes and Metabolism
Q147 / 232
Category: Medicine
Subcategory: Biochemistry
Q1101 / 428
Category: Medicine
Subcategory: Clinical Biochemistry
Q229 / 113

自引率 (2023-2024)2.90%自引率趨勢
掲載範囲
Metabolomics publishes current research regarding the development of technology platforms for metabolomics. This includes, but is not limited to:

metabolomic applications within man, including pre-clinical and clinical
pharmacometabolomics for precision medicine
metabolic profiling and fingerprinting
metabolite target analysis
metabolomic applications within animals, plants and microbes
transcriptomics and proteomics in systems biology
Metabolomics is an indispensable platform for researchers using new post-genomics approaches, to discover networks and interactions between metabolites, pharmaceuticals, SNPs, proteins and more. Its articles go beyond the genome and metabolome, by including original clinical study material together with big data from new emerging technologies.
官方網站https://www.springer.com/11306
在線稿件提交https://submission.nature.com/new-submission/11306/3
開放訪問No
出版商Springer US
主題領域医学
出版國/地區UNITED STATES
發行頻率四半期刊行
創刊年2005
每年文章數102每年文章數趨勢
黃金OA百分比39.03%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ENDOCRINOLOGY & METABOLISMSCIEQ268/186
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1573-3882%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: About 3.0 month(s)
競爭力 *來自作者的數據: About 50%
參考鏈接
相關期刊 【Metabolomics】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Nature Reviews EndocrinologyH-index: 116

    CiteScore: 42.00
    Cell MetabolismH-index: 219

    CiteScore: 48.60
    ENDOCRINE REVIEWSH-index: 257

    CiteScore: 42.00
    DIABETES CAREH-index: 328

    CiteScore: 29.50
    TRENDS IN ENDOCRINOLOGY AND METABOLISMH-index: 146

    CiteScore: 20.10
    METABOLISM-CLINICAL AND EXPERIMENTALH-index: 122

    CiteScore: 18.90
    Cardiovascular DiabetologyH-index: 64

    CiteScore: 12.30
    DIABETOLOGIAH-index: 207

    CiteScore: 18.10
    JOURNAL OF PINEAL RESEARCHH-index: 113

    CiteScore: 17.70
    Obesity ReviewsH-index: 137

    CiteScore: 19.30
    學科內最受檢索的期刊 頁面查看次數
    FREE RADICAL BIOLOGY AND MEDICINE190522
    Cell Metabolism129563
    DIABETES101825
    JOURNAL OF PINEAL RESEARCH94449
    BIOLOGICAL TRACE ELEMENT RESEARCH92704
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM81232
    ANTIOXIDANTS & REDOX SIGNALING79787
    DIABETES CARE73282
    BONE70360
    Obesity68260
  •  

    Metabolomics Metabolomics
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    下一頁    末頁  (頁
/2)
  [Metabolomics] 的評論撰寫評論
作者: 竞一姑娘


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-20 17:53:12 評論於
The review process is very slow, the editor said they couldn't find reviewers, it's been 10 months already, can we have some good news, graduation is almost here
(0) 讚! | 竞一姑娘

作者: 血天俊哲


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-30 14:59:44 評論於
Review speed: 6.0
Emphasis research direction: Metabolism
Metabolomics experience sharing: Submitted on May 28th, and still have not received the review comments as of August 30th!
(0) 讚! | 血天俊哲

作者: Enid Maltz


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-27 23:02:42 評論於
How long does it take for typesetting to be completed after receiving it, and how much does it cost to publish?
(0) 讚! | Enid Maltz

作者: 冬马睿诚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-22 21:06:23 評論於
Review speed: 3.0 | Submission hit rate: 50.0
Experience sharing: On November 17, 2021, submission (requires corresponding author approval). On November 29, it was submitted after review, and the status is Editor Assignment Pending. On December 9, Under Review. On February 9, Major Revision. On March 27, resubmitted, status as revised submission. On March 30, Under Review. On April 20, accepted
(0) 讚! | 冬马睿诚

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 23:03:00 評論於
Refine your hypothesis or innovation point. The best title should use the fewest necessary terms to accurately describe the content of the paper. Writing requirements: accuracy, brevity, clarity, and attractiveness
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 13:07:59 評論於
Normally, each journal has specific requirements for articles, and there is also a checklist that can be used as a reference. You can also refer to articles already published in the target journal when writing
(0) 讚! | 维尔娜菲茨杰拉德

作者: 深渊兴业


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 17:00:37 評論於
How to Craft/Write Article Headlines?
(0) 讚! | 深渊兴业

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 14:56:39 評論於
Is there a writing template for SCI articles?
(0) 讚! | 上清雨真

作者: 六脉曼音


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-09-23 21:02:26 評論於
Review speed: 6.0 
Emphasis research direction: Metabolomics 
Experience sharing: Submitted on 2021.5.15, first review on 2021.8.4 with major revisions suggested. Revised manuscript returned on 2021.9.19. Accepted on 2021.9.21. Did not expect the acceptance to be so quick after revisions
(0) 讚! | 六脉曼音

作者: 一条小向南


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-04-27 21:36:58 評論於
Focused research direction: Metabolomics experience sharing: Do we need to upload data when submitting to Metabolomics journal?
(0) 讚! | 一条小向南

作者: Newman William


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-09-16 11:40:33 評論於
How is it going? Did you revise it?
(0) 讚! | Newman William

作者: 子兴来了


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-07-24 17:26:14 評論於
Review Speed: 3.0
Experience Sharing: First submission, review process took three months and I got rejected. The status of the date remained unchanged throughout. Only received feedback from one reviewer who did not evaluate the article, just commented on language and format. The only suggestion was to include a chart for better understanding, and to focus on the submission direction. The reviewer's feedback was constructive, but given the tight schedule, it's better not to submit as the process is really slow
(0) 讚! | 子兴来了

作者: Paul Whitehead


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-01-31 16:03:48 評論於
Minor revision. Received feedback the day after. 182****8260 2019-01-30 asked: After replying to the first round of comments, the status of the manuscript changed to editor assignment pending. How long does it usually take for the status to change to accept or reject?
(0) 讚! | Paul Whitehead

作者: Paul Whitehead


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-01-30 15:07:14 評論於
May I ask how long it will take for the status of the manuscript to change to "editor assignment pending" after replying to the first review comments? How long does it usually take before I receive a decision on acceptance or rejection?
(0) 讚! | Paul Whitehead

作者: 无击语柔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-08-06 10:09:42 評論於
The first review took two months, and it took seven weeks to receive feedback on the revised manuscript. After resubmitting it a month ago, there has been no response. How long does it usually take for the second review to come back?
(0) 讚! | 无击语柔

作者: 无击语柔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-04-23 10:02:33 評論於
May I ask how long is the current review period for metabolomics? It has been a month since I submitted and I still haven't received any updates!
(0) 讚! | 无击语柔

作者: 金山庆叶


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-11-04 09:22:31 評論於
It has been fluctuating between 3 and 4 for many years
(0) 讚! | 金山庆叶

作者: 琼思Sama


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-10-31 10:06:26 評論於
It has been 4 months since the article was submitted for review, but there has been no news at all. Has anyone encountered this situation before?
(0) 讚! | 琼思Sama

作者: 新荣mio


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-08-07 08:20:09 評論於
Is there any article on receiving thyroid cancer, surgery?
(0) 讚! | 新荣mio

作者: 玄虚越彬


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-09-09 23:37:57 評論於
Is this magazine free?
(0) 讚! | 玄虚越彬

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2012-10-19 14:33:05 評論於
Review speed: 1.0 | Submission acceptance rate: 50.0
Experience sharing: The journal is now a monthly publication, with a review speed of around 1 month, and acceptance within 1 month after revisions. Overall, submitting articles feels relatively easy, with a focus on simplicity. Submissions emphasize the reliability of methods, completeness of stories, and do not require high levels of innovation
(0) 讚! | 凌霄高洁

作者: 匿名


領域: 生命科学
審稿時間: 0.0 month(s)
結果:


撰寫評論

2011-11-29 09:48:00 評論於
 (0) 讚! | 匿名  

作者: 匿名


領域:
審稿時間: 0.0 month(s)
結果:


撰寫評論

2011-01-15 19:59:00 評論於
As a newly published journal, it is still relatively good to select, easy!High impact factor, high number of citations, high quality!
(0) 讚! | 匿名

作者: 铭轩酱吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2010-10-08 19:06:54 評論於
This magazine is a quarterly publication, with not many articles in a year, so it is reasonable for the review process to be long
(0) 讚! | 铭轩酱吖

作者: 匿名


領域: 代谢组学
審稿時間: 0.0 month(s)
結果:


撰寫評論

2010-08-16 16:32:00 評論於
As a newly published journal, the quality of the article is very high and the requirements for originality are higher. It is very selective.

(0) 讚! | 匿名

首頁    上一頁    1    2    下一頁    末頁  (頁
/2)

開始撰寫 [Metabolomics] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*